13F-HR filed by PSP Research LLC
PSP Research LLC filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-04-17, with 79 holding rows worth $141,329,716.
- Accession
- 0001951757-26-000630
- Filer
- CIK 2106939
- Filed
- 2026-04-17
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2026
A holdings report, 79 entries on the cover page, a total value of $141,329,716 stated on the cover page (in dollars after the unit check, H1), rows summing to $141,329,716 with VALUE read as dollars as filed, 13F file number 028-26116. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| iShares 0-3 Month Treasury Bond ETF | 46436E718 | SHS | 700,000 | $70,462,000 | dollars as filed | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 284,900 | $36,390,277 | dollars as filed | |
| SERA PROGNOSTICS INC | 81749D107 | CMN | 2,396,685 | $4,865,271 | dollars as filed | |
| DEFINIUM THERAPEUTICS INC | 24477V105 | COM SHS | 34,800 | $657,720 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 16,000 | $612,800 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 2,500 | $571,825 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 20,000 | $565,000 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 8,300 | $547,053 | dollars as filed | |
| ROYALTY PHARMA PLC | G7709Q104 | SHS CLASS A | 11,000 | $527,670 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 6,300 | $524,727 | dollars as filed | |
| HALOZYME THERAPEUTICS INC COM | 40637H109 | Stock | 8,026 | $518,720 | dollars as filed | |
| EXELIXIS INC COM | 30161Q104 | Stock | 11,948 | $512,450 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 8,000 | $511,520 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 6,800 | $510,612 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 15,000 | $507,450 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 3,848 | $506,936 | dollars as filed | |
| INCYTE CORP COM | 45337C102 | Stock | 5,300 | $498,836 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 7,000 | $491,050 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 15,000 | $488,100 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 1,465 | $484,725 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 1,500 | $483,285 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 2,845 | $480,862 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 15,000 | $480,150 | dollars as filed | |
| ARDELYX INC | 039697107 | COM | 80,000 | $479,200 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 19,200 | $476,928 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 641 | $468,090 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 20,000 | $467,200 | dollars as filed | |
| INHIBRX BIOSCIENCES INC | 45720N103 | COM | 6,927 | $465,702 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 19,700 | $464,132 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 22,100 | $462,995 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 5,000 | $461,900 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 12,000 | $461,880 | dollars as filed | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 28,000 | $460,600 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 15,141 | $456,501 | dollars as filed | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 9,500 | $451,915 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 6,000 | $445,560 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 28,700 | $444,850 | dollars as filed | |
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 30,000 | $444,600 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 19,766 | $439,991 | dollars as filed | |
| RAPPORT THERAPEUTICS INC COM | 75383L102 | Stock | 14,000 | $438,060 | dollars as filed | |
| IMMUNOME INC | 45257U108 | COM | 20,000 | $437,400 | dollars as filed | |
| KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A | G52694109 | Stock | 9,000 | $433,350 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 13,000 | $431,860 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 5,000 | $419,600 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 13,000 | $412,360 | dollars as filed | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 6,000 | $408,780 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 10,000 | $402,300 | dollars as filed | |
| HARMONY BIOSCIENCES HLDGS IN | 413197104 | COM | 14,283 | $400,067 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 11,000 | $399,520 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 71,000 | $392,630 | dollars as filed | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 12,000 | $390,720 | dollars as filed | |
| KODIAK SCIENCES INC | 50015M109 | COM | 10,000 | $381,200 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 20,000 | $362,600 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 30,000 | $357,900 | dollars as filed | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 26,900 | $344,858 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 3,000 | $316,200 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 600 | $314,082 | dollars as filed | |
| SUPERNUS PHARMACEUTICALS | 868459108 | COM | 6,000 | $310,140 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 14,400 | $301,248 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 17,327 | $280,351 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 7,000 | $274,400 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 5,159 | $260,220 | dollars as filed | |
| ZYMEWORKS INC | 98985Y108 | COM | 10,000 | $250,400 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 4,200 | $244,230 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 4,968 | $243,680 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 2,000 | $228,280 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 10,795 | $217,303 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 12,000 | $217,080 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 6,000 | $212,160 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 2,500 | $210,425 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 350 | $207,543 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 6,500 | $204,750 | dollars as filed | |
| SUMMIT THERAPEUTICS INC | 86627T108 | COM | 10,223 | $193,828 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 13,000 | $164,710 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 30,000 | $158,700 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 10,838 | $150,648 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 10,000 | $149,100 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 10,000 | $128,900 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 15,000 | $127,050 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001951757-26-000630 | this filing | 2026-04-17 | acceptance time not in the bulk data set |